Core-Oli-T AB: Development of Monoclonal Antibodies with Diagnostic and Therapeutic Applicability
We develop innovative antibody applications for the diagnosis and treatment of Parkinson’s disease.
Ground-breaking Solutions for Parkinson’s Disease
Core-Oli-T AB develops innovative monoclonal antibodies to support the diagnosis and treatment of Parkinson’s disease, with a focus on improving patients’ quality of life.
Core-Oli-T AB: Innovative Antibodies against Parkinson’s Disease
Discover our groundbreaking monoclonal antibodies that support diagnostics and treatment.
Precision diagnostics
Our antibodies enable early and accurate identification of Parkinson’s disease.
Ground-breaking therapeutics
Development of treatments that improve the quality of life for patients.
Sustainable research
Focus on innovative research with long-term results in life science.
Custom-made solutions
Customized antibodies for various diagnostic and therapeutic needs.
Expert team
A committed team with cutting-edge expertise in biotechnology and medical development.
Towards early-stage antibody-based diagnostics and therapies against Parkinson’s disease
This section describes the challenges of Parkinson’s and how our monoclonal antibodies offer powerful solutions.
Precision antibodies for early diagnosis
Our antibodies enable rapid and accurate identification of Parkinson’s biomarkers.
Therapeutic antibodies
We provide antibodies that improve treatment efficacy and reduce symptoms.
Precision antibodies for later-stage brain imaging
Our solutions enable new understanding and better research results in Parkinson’s disease.
Askvägen 23
SE-394 70, Kalmar, Sweden
+46 72 22 18 225
info@core-oli-t.com